跳至主要内容
临床试验/NCT06123767
NCT06123767尚未招募不适用

Evaluation of Diagnostic and Predictive Capabilities of Novel Application of Carotid Carotid Stenosis Pressure Gradient Measurement in Patients Undergoing Percutaneous Carotid Angioplasty and Stenting (CAS).

4th Military Clinical Hospital with Polyclinic, Poland2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
200
试验地点
2
主要终点
Predictive capabilities of the obtained invasive pressure gradient in carotid artery stenosis on changes in cerebral perfusion after surgery

研究概览

简要总结

About 20% of stroke causes are atherosclerotic strokes caused by carotid artery stenosis.

In 2005, 92% of carotid artery interventions in the USA were performed in asymptomatic patients. It should be noted that screening in the general population for carotid artery disease is unwarranted, due to uncertain eligibility criteria for interventional treatment of asymptomatic patients. On the other hand, 10-15% of all patients with a first-ever stroke will experience an ischemic stroke as a result of previously untreated, asymptomatic, significant carotid artery stenosis.

Carotid artery angioplasty with stent placement (CAS) has become the second method of revascularization. ed, however, there is a great deal of ambiguity in the application of these criteria, which stems from the ratio of the risk to the possible benefit to the patient of performing the procedure, as well as the cost-effectiveness for health care systems.

OBJECTIVES The overall goal is (following the model of measuring fractional flow reserve - FFR) to try to establish a new parameter that could prove helpful in qualifying patients for percutaneous internal carotid artery angioplasty with stent implantation (CAS). Determining whether measuring the pressure gradient across the stenosis will determine which patients will benefit from the CAS procedure. In the absence of convincing evidence on the effects of CAS, especially for so-called asymptomatic patients, it is advisable to establish a parameter that would complement the eligibility criteria that, on the one hand, could prevent strokes in the population of patients with silent internal carotid artery stenosis and, on the other hand, avoid performing the procedure in the absence of benefit.

PRIMARY ENDPOINTS:

  1. Assessment of cerebral perfusion by magnetic resonanse before and after CAS
  2. Assessment of cognitive symptoms using before and after CAS
  3. Assessment of neurological symptoms before and after CAS
  4. Assessment of otolaryngological symptoms before and after CAS

SECONDARY ENDPOINTS:

Creation of a non-invasive computed tomography protocol with pressure gradient assessment in patients with carotid artery stenosis.

A final version of the algorithm based on a new diagnostic measurement (concentration gradient) ready to be used in the diagnosis of CAS-eligible patients with an implemented function for automatic classification of measurement results that will indicate the group of patients who will benefit from the CAS procedure.

详细描述

After qualification for the study (by a neurologist and vascular surgeon), patients meeting properly the inclusion and exclusion criteria will be referred for imaging studies with Doppler ultrasound, angio-CT scan of the arteries of the neck and head and cerebral perfusion in magnetic resonanse (assessment of the cerebral perfusion alterations using DSC (dynamic susceptibility contrast).

In addition, blood will be drawn and stored for subsequent testing. Afterwards, patients qualified for internal carotid artery angioplasty procedures will receive standard saturation treatment with two antiplatelet drugs (acetylsalicylic acid, clopidogrel) before the procedure, strictly according to the guidelines. The procedures are carried out with approved medical equipment (carotid stent, angioplasty balloon, peripheral neuroprotection). The selection of the appropriate equipment used for the procedure depends on the clinical situation, the experience of the operator and the anatomical conditions of the carotid arteries.

Measurements (invasive pressure in carotid artery) taken during the procedure before angioplasty (after insertion of the neuroprotection into the internal carotid artery) and after stent implantation:

COURSE OF THE STUDY

Baseline examination:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

The project is a double-blind study. Neither the researchers nor the participants will know what invasive procedures will be performed on a given patient. Patients, investigators, and all persons involved in performing the procedure or analysis of the data, as well as others with an interest in the study results, will remain blinded to the treatment assigned to individual patients from the beginning of the study until the closure of the database.

Staff involved in the CAS procedure (with or without blood pressure measurement) will not participate in further patient care and will not provide information to other researchers and people conducting therapy and diagnostics.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Stenosis of the internal carotid artery in symptomatic patients: > 50%, (confirmed by non-invasive imaging studies: USG, angio-CT), qualified for angioplasty with stent implantation
  • Stenosis of the internal carotid artery in asymptomatic patients: >60%, (confirmed by non-invasive imaging studies: USG, angio-CT), qualified for angioplasty with stent implantation
  • Age of patients: > 18 years of age
  • Provided informed consent to participate in the study.

排除标准

  • Inability to obtain informed consent to participate in the study.
  • Difficult anatomy of the aortic arch and the descending cephalic arteries (increased atherosclerotic lesions, acute angle of departure of the common carotid arteries, kinking of the internal carotid arteries).

研究组 & 干预措施

CAS (standard)

Active Comparator

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure.

干预措施: Otolaryngological examination (Other)

CAS (standard)

Active Comparator

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure.

干预措施: Psychological examination (Other)

CAS (standard)

Active Comparator

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure.

干预措施: Neurological examination (Other)

CAS (standard)

Active Comparator

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure.

干预措施: MR cerebral perfusion (Diagnostic Test)

CAS + Intravascular measuring the pressure gradient

Experimental

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure with additional intravascular pressure measurements

干预措施: CAS + Intravascular measuring the pressure gradient (Procedure)

CAS + Intravascular measuring the pressure gradient

Experimental

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure with additional intravascular pressure measurements

干预措施: CAS (standard) (Procedure)

CAS + Intravascular measuring the pressure gradient

Experimental

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure with additional intravascular pressure measurements

干预措施: Doppler ultrasonound of cephalic arteries (Diagnostic Test)

CAS + Intravascular measuring the pressure gradient

Experimental

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure with additional intravascular pressure measurements

干预措施: Angio-CT of the neck and head (Radiation)

CAS + Intravascular measuring the pressure gradient

Experimental

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure with additional intravascular pressure measurements

干预措施: Otolaryngological examination (Other)

CAS + Intravascular measuring the pressure gradient

Experimental

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure with additional intravascular pressure measurements

干预措施: Psychological examination (Other)

CAS + Intravascular measuring the pressure gradient

Experimental

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure with additional intravascular pressure measurements

干预措施: Neurological examination (Other)

CAS + Intravascular measuring the pressure gradient

Experimental

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure with additional intravascular pressure measurements

干预措施: MR cerebral perfusion (Diagnostic Test)

CAS (standard)

Active Comparator

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure.

干预措施: CAS (standard) (Procedure)

CAS (standard)

Active Comparator

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure.

干预措施: Doppler ultrasonound of cephalic arteries (Diagnostic Test)

CAS (standard)

Active Comparator

Patients with internal carotid stenosis qualified for angioplasty with stent implantation.

Standard CAS procedure.

干预措施: Angio-CT of the neck and head (Radiation)

结局指标

主要结局

Predictive capabilities of the obtained invasive pressure gradient in carotid artery stenosis on changes in cerebral perfusion after surgery

时间窗: 3 months

Composite endpoint including: Assessment of the predictive capabilities of the obtained pressure gradient values * on changes in cerebral perfusion after surgery (assessment of the cerebral perfusion alterations using DSC (dynamic susceptibility contrast) MR perfusion, before and after CAS

Predictive capabilities of the obtained invasive pressure gradient in carotid artery stenosis on mental status

时间窗: 12 months

Composite endpoint including: \- changes in cognitive functions (assesed by the MOCA, Montreal Cognitive Assessment - test)

Predictive capabilities of the obtained invasive pressure gradient in carotid artery stenosis on neurological status

时间窗: 12 months

Composite endpoint including: \- changes in neurological status (assesed by the MMSE, mini-mental state examination; NIHSS, National Institutes of Health Stroke Scale),

Predictive capabilities of the obtained invasive pressure gradient in carotid artery stenosis on otolaryngological status in hearing functions

时间窗: 12 months

Composite endpoint including: \- changes in hearing functions (assesed by the audiometry, tympanometry and ipsilateral middle ear reflex, otoemission, Skarzynski Tinnitus Scale, ABR - Auditory Brainstem Response, BERA)

Predictive capabilities of the obtained invasive pressure gradient in carotid artery stenosis on otolaryngological status in labyrinth functions

时间窗: 12 months

Composite endpoint including: \- changes in labyrinth functions (assesed by the Skarzynski Tinnitus Scale)

Predictive capabilities of the obtained invasive pressure gradient in carotid artery stenosis on MACEs after surgery

时间窗: 12 months

Composite endpoint including: \- occurence of stroke/TIA or death

Repeatability the diagnostic possibilities of non-invasive tests (Doppler ultrasound) in invasive pressure gradient values

时间窗: 12 months

Composite endpoint including: \- comparison of the obtained invasive pressure gradient values with Doppler ultrasound (PSV, peak systolic velocity; EDV, end-diastolic velocity; estimated degree of stenosis)

Repeatability the diagnostic possibilities of non-invasive tests (CT angiogram) in invasive pressure gradient values

时间窗: 12 months

Composite endpoint including: \- comparison of the obtained invasive pressure gradient values with angio-CT: degree of stenosis

Repeatability the diagnostic possibilities of non-invasive tests ("CT-FFR") in invasive pressure gradient values

时间窗: 12 months

Composite endpoint including: \- comparison of the obtained invasive pressure gradient values with "CT-FFR" (planned creation of an algorithm based on test results: invasive pressure gradient, Doppler ultrasound, angio-CT)

Incidence of Treatment-Related Adverse Events [safety and tolerability] associated with the invasive intravascular pressure measurement procedure (1)

时间窗: 12 months

Composite endpoint including: \- occurrence of periprocedural neurological event: TIA, stroke, death in patients who underwent CAS with the invasive intravascular pressure measurement procedure

Incidence of Treatment-Related Adverse Events [safety and tolerability] associated with the invasive intravascular pressure measurement procedure (2)

时间窗: 12 months

Composite endpoint including: \- occurrence of another periprocedural complication: vascular spasm, perforation, cardiac arrhythmia, hypotonia/hypertension in patients who underwent CAS with the invasive intravascular pressure measurement procedure

Incidence of Treatment-Related Adverse Events [safety and tolerability] associated with the invasive intravascular pressure measurement procedure (3)

时间窗: 12 months

Composite endpoint including: \- occurrence of new hypodense (impact) foci in the head CT scan after the procedure in patients who underwent CAS with the invasive intravascular pressure measurement procedure

Incidence of Treatment-Related Adverse Events [safety and tolerability] associated with the invasive intravascular pressure measurement procedure (4)

时间窗: 12 months

Composite endpoint including: \- changes (improvement or deterioration) in brain perfusion (see point 1.) in the post-operative examination in patients who underwent CAS with the invasive intravascular pressure measurement procedure

次要结局

  • Algorithm angio-CT/non invasive pressure measurement in carotid(48 months)

研究者

发起方
4th Military Clinical Hospital with Polyclinic, Poland
申办方类型
Other
责任方
Principal Investigator
主要研究者

Krzysztof Ściborski

Vice-Head of Cath Lab; Department of Cardiology, Center for Heart Disease, 4th Military Hospital, Wrocław, Poland

4th Military Clinical Hospital with Polyclinic, Poland

研究点 (2)

Loading locations...

相似试验